Search results for "ARTICLES"

showing 10 items of 9626 documents

Continuously manufactured magnetic polymersomes--a versatile tool (not only) for targeted cancer therapy.

2013

Micromixer technology was used to prepare polymeric vesicles (Pluronic® L-121) dual loaded with the anti-cancer drug camptothecin and magnetic nanoparticles. Successful incorporation of the magnetic nanoparticles was confirmed by transmission electron microscopy. Dynamic light scattering measurements showed a relatively narrow size distribution of the hybrid polymersomes. Camptothecin polymersomes reduced the cell viability of prostate cancer cells (PC-3) measured after 72 h significantly, while drug-free polymersomes showed no cytotoxic effects. Covalent attachment of a cancer targeting peptide (bombesin) as well as a fluorescent label (Alexa Fluor® 647) to the hybrid polymersomes was perf…

BiodistributionRelaxometryMaterials scienceCell SurvivalMicromixerNanotechnologyAntineoplastic AgentsPoloxamerlaw.inventionPolyethylene GlycolsConfocal microscopylawCell Line TumorNeoplasmsmedicineHumansGeneral Materials SciencePrecision MedicineMagnetite NanoparticlesDrug CarriersCarbocyaninesPropylene GlycolsDrug deliveryPolymersomeMagnetic nanoparticlesBombesinCamptothecinCamptothecinmedicine.drugNanoscale
researchProduct

Density of conjugated antibody determines the extent of Fc receptor dependent capture of nanoparticles by liver sinusoidal endothelial cells

2021

Despite considerable progress in the design of multifunctionalized nanoparticles (NPs) that selectively target specific cell types, their systemic application often results in unwanted liver accumulation. The exact mechanisms for this general observation are still unclear. Here we asked whether the number of cell-targeting antibodies per NP determines the extent of NP liver accumulation and also addressed the mechanisms by which antibody-coated NPs are retained in the liver. We used polysarcosine-based peptobrushes (PBs), which in an unmodified form remain in the circulation for >24 h due to the absence of a protein corona formation and low unspecific cell binding, and conjugated them with …

Biodistributionbiologymedicine.diagnostic_testChemistryCellGeneral EngineeringFc receptorGeneral Physics and AstronomyEndothelial CellsDendritic cellReceptors FcFlow cytometryCell biologymedicine.anatomical_structureLiverbiology.proteinmedicineSystemic administrationNanoparticlesGeneral Materials ScienceTissue DistributionAntibodyReceptor
researchProduct

Effect of endothelial cell heterogeneity on nanoparticle uptake.

2020

Endothelial cells exhibit distinct properties in morphology and functions in different organs that can be exploited for nanomedicine targeting. In this work, endothelial cells from different organs, i.e. brain, lung, liver, and kidney, were exposed to plain, carboxylated, and amino-modified silica. As expected, different protein coronas were formed on the different nanoparticle types and these changed when foetal bovine serum (FBS) or human serum were used. Uptake efficiencies differed strongly in the different endothelia, confirming that the cells retained some of their organ-specific differences. However, all endothelia showed higher uptake for the amino-modified silica in FBS, but, inter…

Biodistributionmedia_common.quotation_subjectReceptor expressionEndothelial cellsBristol Heart InstitutePharmaceutical ScienceUptake02 engineering and technologyADHESIONBlood–brain barrier030226 pharmacology & pharmacySERUM03 medical and health sciencesDELIVERY0302 clinical medicineBIODISTRIBUTIONmedicineHumansBovine serum albuminInternalization/dk/atira/pure/core/keywords/heart_SRImedia_commonchemistry.chemical_classificationKidneyPROTEIN-CORONAbiologyChemistryBLOOD-BRAIN-BARRIEREndothelial CellsBiological Transportrespiratory system021001 nanoscience & nanotechnologyCell biologyEndothelial stem cellSURFACE-CHARGEmedicine.anatomical_structureSIZENanomedicineTransferrinProtein coronabiology.proteinINTERNALIZATIONNanoparticlesProtein CoronaHeterogeneityMEMBRANE0210 nano-technologyEndothelial cell targetingInternational journal of pharmaceutics
researchProduct

Granulocyte Colony-Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part I): Synthesis and Biodistribution Studies

2018

In the field of cancer immunotherapy, an original approach consists of using granulocyte colony-stimulating factor (G-CSF) to target and activate neutrophils, cells of the innate immune system. G-CSF is a leukocyte stimulating molecule which is commonly used in cancer patients to prevent or reduce neutropenia. We focused herein on developing a G-CSF nanocarrier which could increase the in vivo circulation time of this cytokine, keeping it active for targeting the spleen, an important reservoir of neutrophils. G-CSF-functionalized silica and gold nanoparticles were developed. Silica nanoparticles of 50 nm diameter were functionalized by a solid phase synthesis approach. The technology enable…

Biodistributionmedicine.medical_treatmentBiomedical EngineeringPharmaceutical ScienceBioengineering02 engineering and technology010402 general chemistry01 natural sciences[ SDV.CAN ] Life Sciences [q-bio]/CancerMiceDrug Delivery SystemsImmune systemAdjuvants ImmunologicCancer immunotherapyIn vivoGranulocyte Colony-Stimulating FactorPEG ratiomedicineAnimals[CHIM]Chemical SciencesTissue Distribution[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyComputingMilieux_MISCELLANEOUSPharmacologyDrug CarriersChemistryOrganic ChemistrySilicon Dioxide021001 nanoscience & nanotechnology3. Good health0104 chemical sciencesGranulocyte colony-stimulating factorColloidal goldBiophysicsNanoparticlesGoldNanocarriers0210 nano-technologySpleenBiotechnologyBioconjugate Chemistry
researchProduct

Mammal assemblage composition predicts global patterns in emerging infectious disease risk

2021

Abstract As a source of emerging infectious diseases, wildlife assemblages (and related spatial patterns) must be quantitatively assessed to help identify high‐risk locations. Previous assessments have largely focussed on the distributions of individual species; however, transmission dynamics are expected to depend on assemblage composition. Moreover, disease–diversity relationships have mainly been studied in the context of species loss, but assemblage composition and disease risk (e.g. infection prevalence in wildlife assemblages) can change without extinction. Based on the predicted distributions and abundances of 4466 mammal species, we estimated global patterns of disease risk through …

BiodiversityDIVERSITYAnimal Sciences DeskzoonoositCommunicable Diseases EmergingeläinmaantiedetartuntatauditBureau DierwetenschappenPrimary Research ArticleGeneral Environmental ScienceBODY-SIZEMammals2. Zero hungerGlobal and Planetary ChangeEcologyEcologyassemblage composition; climate change; emerging infectious diseases; habitat loss; infectious disease hotspots; species distributionsassemblage compositionPOPULATION-DENSITYeliöyhteisötriskinarviointiPE&RCEXTINCTION RISKclimate changespecies distributions1181 Ecology evolutionary biologyEmerging infectious diseaseWILDLIFEhabitat lossWildlifeContext (language use)Biologyemerging infectious diseasesEVENNESSnisäkkäätAnimalsEnvironmental ChemistryeläimistöEcosystemPATHOGENSSPECIES DISTRIBUTION MODELS15. Life on landilmastonmuutoksetPrimary Research ArticlesbiodiversiteettiHabitat destruction13. Climate actionInfectious disease (medical specialty)villieläimetWildlife Ecology and ConservationSpatial ecologyBIODIVERSITYSpecies richnessLIVING FASTEnvironmental Sciencesinfectious disease hotspots
researchProduct

New evidence for the multiplicity of ubiquinone- and inhibitor-binding sites in the mitochondrial complex I.

2000

Determination of the number of ubiquinone- and inhibitor-binding sites in the mitochondrial complex I (NADH:ubiquinone oxidoreductase) is a controversial question with a direct implication for elaborating a suitable model to explain the bioenergetic mechanism of this complicated enzyme. We have used combinations of both selective inhibitors and common ubiquinone-like substrates to demonstrate the multiplicity of the reaction centers in the complex I in contrast with competition studies that have suggested the existence of a unique binding site for ubiquinone. Our results provide new evidence for the existence of at least two freely exchangeable ubiquinone-binding sites with different specif…

BioenergeticsStereochemistryUbiquinoneSubmitochondrial ParticlesBiophysicsBiologyIn Vitro TechniquesBiochemistryModels BiologicalMitochondria HeartSubstrate SpecificityOxidoreductaseAnimalsNADH NADPH OxidoreductasesBinding siteMultiplicity (chemistry)Molecular Biologychemistry.chemical_classificationNADH-Ubiquinone OxidoreductaseBinding SitesElectron Transport Complex IKineticsEnzymechemistryBiochemistryCattleEnergy MetabolismMitochondrial Complex IArchives of biochemistry and biophysics
researchProduct

Structural analysis and biochemical properties of laccase enzymes from two Pediococcus species

2021

Summary Prokaryotic laccases are emergent biocatalysts. However, they have not been broadly found and characterized in bacterial organisms, especially in lactic acid bacteria. Recently, a prokaryotic laccase from the lactic acid bacterium Pediococcus acidilactici 5930, which can degrade biogenic amines, was discovered. Thus, our study aimed to shed light on laccases from lactic acid bacteria focusing on two Pediococcus laccases, P. acidilactici 5930 and Pediococcus pentosaceus 4816, which have provided valuable information on their biochemical activities on redox mediators and biogenic amines. Both laccases are able to oxidize canonical substrates as ABTS, ferrocyanide and 2,6‐DMP, and non‐…

BioengineeringApplied Microbiology and BiotechnologyBiochemistry03 medical and health scienceschemistry.chemical_compoundPediococcusResearch Articles030304 developmental biologyLaccasechemistry.chemical_classification0303 health sciencesABTSBacteriabiology030306 microbiologyChemistryLaccaseSubstrate (chemistry)Pediococcus acidilacticifood and beveragesbiology.organism_classificationLactic acidEnzymeProkaryotic CellsBiochemistryPediococcusOxidation-ReductionBacteriaTP248.13-248.65Research ArticleBiotechnologyMicrobial Biotechnology
researchProduct

Interspecies interactions mediated by conductive minerals in the sediments of the ferruginous Lake La Cruz, Spain

2018

AbstractLake La Cruz is considered a biogeochemical analogue to early Earth marine environments because its water column is depleted in sulfate, but rich in methane and iron, similar to conditions envisaged for much of the Precambrian. In this early Earth analogue environment, we show that conductive particles establish a tight metabolic coupling between electroactive microbial clades. We propose that mineral-based syntrophy is of potential relevance for the evolution of Earth’s earliest complex life forms. We show that the anoxic sediment of Lake La Cruz, which is rich in biogeochemically ‘reactive’ iron minerals, harbors known electroactive species such asGeobacterandMethanothrix,in addit…

Biogeochemical cyclemagnetitedirect interspecies electron transfer (DIET)granular activated carbonMethanothrixMethanothrix03 medical and health scienceschemistry.chemical_compoundWater columnSyntrophymineral mediated syntrophy14. Life underwaterSulfate030304 developmental biology0303 health sciencesbiology030306 microbiologySediment15. Life on landbiology.organism_classificationAnoxic watersferruginous lakeconductive particleschemistry13. Climate actionEnvironmental chemistryYoungiibacterGeobacterGeobacter
researchProduct

Polymeric Nanoparticles: Polymeric Nanoparticles with Neglectable Protein Corona (Small 18/2020)

2020

BiomaterialsMaterials scienceChemical engineeringAsymmetrical Flow Field-Flow FractionationDrug deliveryGeneral Materials ScienceProtein CoronaGeneral ChemistryPolymeric nanoparticlesBiotechnologySmall
researchProduct

Combination of silica nanoparticles with hydroxyapatite reinforces poly (l-lactide acid) scaffolds without loss of bioactivity

2013

Composite scaffolds of poly(l-lactide acid) and hydroxyapatite are of great interest in bone tissue engineering, but their mechanical properties are typically inferior to scaffolds of pure poly(l-lactide acid) due to agglomeration of the particles and weak interfacial component interaction. Fabrication strategies like double sonication of hydroxyapatite or increasing the amount of this inorganic filler do not effectively enhance the mechanical performance. In this study, poly(l-lactide acid) composites combining two types of fillers, mesoporous silica (SiO2) nanoparticles and hydroxyapatite, were developed to reinforce the poly(l-lactide acid) scaffold without any loss of bioactivity. A 5%…

BiomaterialsSilica nanoparticlesMaterials sciencePolymers and PlasticsChemical engineeringPoly-L-lactideComposite numberMaterials ChemistryBioengineeringBone tissue engineeringJournal of Bioactive and Compatible Polymers
researchProduct